Company Overview

Tradeweb Markets Inc. builds and operates electronic marketplaces in the Americas, Europe, the Middle East, Africa, Asia Pacific, and internationally. The company's marketplaces facilitate trading in a range of asset classes, including rates, credit, money markets, and equities. It offers pre-trade data and analytics, trade execution, and trade processing, as well as post-trade data, analytics, and reporting services. The company provides flexible order and trading systems to institutional investors in 45 markets across 25 currencies. It also offers a range of electronic, voice, and hybrid platforms to approximately 300 dealers and financial institutions on electronic or hybrid markets with Dealerweb platform; and trading solutions for financial advisory firms and traders with Tradeweb Direct platform. The company serves a network of approximately 2,500 clients in the institutional, wholesale, and retail client sectors. Its customers include asset managers, hedge funds, insurance companies, central banks, banks and dealers, proprietary trading firms, retail brokerage and financial advisory firms, and regional dealers. Tradeweb Markets Inc. was founded in 1996 and is headquartered in New York, New York. Tradeweb Markets Inc. is a subsidiary of Refinitiv Parent Limited.

  • Name

    Tradeweb Markets Inc.

  • CEO

    Mr. William E. Hult

  • Website

    www.tradeweb.com

  • Sector

    Capital Markets

  • Year Founded

    1996

Profile

  • Market Cap

    $23.84B

  • EV

  • Shares Out

    213.23M

  • Revenue

    $1,510.7M

  • Employees

    1,179

Margins

  • Gross

    94.26%

  • EBITDA

  • Operating

  • Pre-Tax

    43.16%

  • Net

    28.68%

  • FCF

    50.77%

Returns (5Yr Avg)

  • ROA

    4.2%

  • ROTA

    6.38%

  • ROE

    4.78%

  • ROCE

  • ROIC

    6.01%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $119.93

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,718.23M

  • Net Debt

    -$1,690.13M

  • Debt/Equity

    0

  • EBIT/Interest

Growth (CAGR)

  • Rev 3Yr

    15.56%

  • Rev 5Yr

    15.94%

  • Rev 10Yr

  • Dil EPS 3Yr

    23.57%

  • Dil EPS 5Yr

    26.8%

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    18.74%

  • EBITDA Fwd 2Yr

    18.4%

  • EPS Fwd 2Yr

    18.73%

  • EPS LT Growth Est

    19.22%

Dividends

  • Yield

  • Payout

    18.64%

  • DPS

    $0.38

  • DPS Growth 3Yr

    5.9%

  • DPS Growth 5Yr

    36.56%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    12.27%

NasdaqGS:TW